In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

Abstract Novel tuberculosis (TB)-vaccines preferably should (i) boost host immune responses induced by previous BCG vaccination and (ii) be directed against Mycobacterium tuberculosis (Mtb) proteins expressed throughout the Mtb infection-cycle. Human Mtb antigen-discovery screens identified antigens...

Full description

Bibliographic Details
Main Authors:	Mariateresa Coppola, Fabienne Jurion, Susan J. F. van den Eeden, Hermann Giresse Tima, Kees L. M. C. Franken, Annemieke Geluk, Marta Romano, Tom H. M. Ottenhoff
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-06-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-021-00343-2

Similar Items

Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen
by: Nicolas Bruffaerts, et al.
Published: (2014-03-01)

Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.
by: Susanna Commandeur, et al.
Published: (2014-01-01)

Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application
by: Mariateresa Coppola, et al.
Published: (2018-02-01)

BCG and Adverse Events in the Context of Leprosy
by: Renate Richardus, et al.
Published: (2018-04-01)

Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens
by: Antas Paulo RZ, et al.
Published: (2002-01-01)

Protein Levels of Pro-Inflammatory Cytokines and Chemokines as Biomarkers of <i>Mycobacterium bovis</i> Infection and BCG Vaccination in Cattle
by: Hamza Khalid, et al.
Published: (2022-06-01)

Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia
by: Leonar Arroyo, et al.
Published: (2018-01-01)

Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.
by: Sebastian D Schuck, et al.
Published: (2009-01-01)

Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG
by: FABIANA K SEIXAS, et al.
Published: (2010-01-01)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle.
by: Gillian S Dean, et al.
Published: (2015-01-01)

Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae.
by: Kidist Bobosha, et al.
Published: (2014-05-01)

Immunization With Mycobacterium tuberculosis Antigens Encapsulated in Phosphatidylserine Liposomes Improves Protection Afforded by BCG
by: Gil R. Diogo, et al.
Published: (2019-06-01)

Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.
by: Julie Todoroff, et al.
Published: (2013-01-01)

INNOVATIVE STRATEGIES TO IDENTIFY M. TUBERCULOSIS ANTIGENS AND EPITOPES USING GENOME-WIDE ANALYSES
by: Annemieke eGeluk, et al.
Published: (2014-06-01)

Evaluate the efficiency of Antigen 60 (A60) protein from BCG strain of Mycobacterium bovis as a diagnostic antigen
by: Nafiseh Shakibamehr, et al.
Published: (2016-01-01)

Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
by: Nacho Aguilo, et al.
Published: (2017-07-01)

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.
by: Lee, L, et al.
Published: (2011)

CXCR6 Is a Marker for Protective Antigen-Specific Cells in the Lungs after Intranasal Immunization against Mycobacterium tuberculosis
by: Lee, L, et al.
Published: (2011)

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
by: Zhengzhong Xu, et al.
Published: (2023-11-01)

The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
by: Mariateresa Coppola, et al.
Published: (2021-12-01)

Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
by: Mªdel Mar eSerra Vidal, et al.
Published: (2014-10-01)

CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells.
by: Mardi C Boer, et al.
Published: (2014-01-01)

Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01)

Interruption of persistent exposure to leprosy combined or not with recent BCG vaccination enhances the response to Mycobacterium leprae specific antigens.
by: Fernanda Marques de Carvalho, et al.
Published: (2017-05-01)

Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980
by: Guoying Deng, et al.
Published: (2020-03-01)

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
by: Fine, P, et al.
Published: (1996)

Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
by: Nan-Chang Chiu, et al.
Published: (2015-03-01)

Disseminated Mycobacterium bovis Infection after BCG Vaccination
by: Shahla Afshar Paiman, et al.
Published: (2006-09-01)

Study of antigen processing and presentation of tumour antigen recognised by spontaneous T cell responses in cancer patients
by: Wang, W
Published: (2022)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
by: Manuja Gunasena, et al.
Published: (2022-07-01)

Development of Human Cell-Based In Vitro Infection Models to Determine the Intracellular Survival of Mycobacterium avium
by: Gül Kilinç, et al.
Published: (2022-06-01)

Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine
by: Kátia da Silva Calabrese, et al.
Published: (1992-01-01)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01)

A case of Mycobacterium bovis Bacillus Calmette-Guérin (BCG) strain meningitis and ventriculitis following BCG vaccination
by: Mihoko Furuichi, et al.
Published: (2020-11-01)

Auxotrophic <i>Mycobacterium bovis</i> BCG: Updates and Perspectives
by: Odir Antônio Dellagostin, et al.
Published: (2022-05-01)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
by: Patricia Espinosa-Cueto, et al.
Published: (2020-06-01)

BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
by: Paul J Converse, et al.
Published: (2011-03-01)

Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine
by: Antonella Grottola, et al.
Published: (2010-09-01)

Antisera recognising HLA-A, -B and DRW antigens raised in rhesus monkeys.
by: Barnstable, C, et al.
Published: (1980)